ARCHIVES

Also in this 8-page issue: FDA begins search for director of new Office of Oncology Drug Products.

This article is from The Cancer Letter archive.

Vol. 30 No. 38 | October 8, 2004

Download PDF Visit The Full Archive

Related Articles

Senate Appropriations Include Cancer Control, Training Money, But Very Little for Construction

July 8, 1988

In Brief: Phil Amoruso Will Be The New NCI Executive Officer; DRCCA Board Okays CCN Extension

January 2, 1981

In Brief: McDonough Leaves Komen Foundation; Henderson To Head Salk Institute; Alabama Recruits Two

December 4, 1992

Genomic Tests Not Shown To Decrease Deaths, Improve Quality Of Life

October 27, 2006

House Subcommittee Recommends $137.7 Million Increase For NCI

June 21, 1996

PD-1 Checkpoint Inhibitor Opdivo First to Demonstrate Survival Benefit in Phase III

November 28, 2014